Related Experiment Video
Updated: Apr 24, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A failed attempt to conduct an individual patient data meta-analysis
Gerald J Jaspers, Pieter L J Degraeuwe1
1Department of Pediatrics, Maastricht University Medical Centre, P, Debyelaan 25, PO Box 5800, 6202AZ Maastricht, The Netherlands. pieter.degraeuwe@mumc.nl.
Proton magnetic resonance spectroscopy shows promise for predicting outcomes in neonatal hypoxic-ischemic encephalopathy. Mandating data sharing could enable more accurate prognostic tools for clinical decisions.
Area of Science:
- Neurology
- Medical Imaging
Background:
- Proton magnetic resonance spectroscopy (MRS) shows potential as a prognostic marker for neonatal hypoxic-ischemic encephalopathy (HIE).
- An individual patient data meta-analysis could enhance prognostic accuracy for HIE, aiding clinical decision-making.
Discussion:
- Data sharing challenges hindered the proposed individual patient data meta-analysis.
- Reasons for non-collaboration included data reanalysis and lack of parental consent, with less than 40% of data becoming available.
Key Insights:
- Proton MRS is a promising prognostic marker in neonatal hypoxic-ischemic encephalopathy.
- Individual patient data meta-analysis is crucial for developing accurate prognostic tools.
Outlook:
- Implementing policies for mandatory data sharing is recommended to facilitate future research.
- Improved data accessibility could lead to better clinical management of HIE.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Bioavailability Study Design: Healthy Subjects Versus Patients
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Dosage Regimen: Individualization
